Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA.

Eberle U, Wimmer C, Huber I, Neubauer-Juric A, Valenza G, Ackermann N, Sing A (2021)

Publication Type: Journal article

Publication year: 2021

Journal

European Journal of Clinical Microbiology & Infectious Diseases Springer Verlag (Germany)

Book Volume: 40

Pages Range: 1303-1308

Journal Issue: 6

DOI: 10.1007/s10096-021-04159-9

Abstract

To face the COVID-19 pandemic, the need for fast and reliable diagnostic assays for the detection of SARS-CoV-2 is immense. We describe our laboratory experiences evaluating nine commercially available real-time RT-PCR assays. We found that assays differed considerably in performance and validation before routine use is mandatory.

Authors with CRIS profile

Giuseppe Valenza Medizinische Fakultät

Involved external institutions

Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit (LGL) DE Germany (DE)

How to cite

APA:

Eberle, U., Wimmer, C., Huber, I., Neubauer-Juric, A., Valenza, G., Ackermann, N., & Sing, A. (2021). Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA. European Journal of Clinical Microbiology & Infectious Diseases, 40(6), 1303-1308. https://dx.doi.org/10.1007/s10096-021-04159-9

MLA:

Eberle, Ute, et al. "Comparison of nine different commercially available molecular assays for detection of SARS-CoV-2 RNA." European Journal of Clinical Microbiology & Infectious Diseases 40.6 (2021): 1303-1308.

BibTeX: Download